← Back to all trials
Completed
NCT07584811
Efficacy and Safety of Overnight Occlusive HA35 Gel for Facial Aesthetic Improvement
Conditions: Facial Subcutaneous Fat, Facial Erythema, Skin Dullness, Nasal Alar Pore Enlargement, Facial Aesthetic Improvement
Sex: All
Ages: 18 Years – 60 Years
Healthy volunteers: No
Phase: NA
Enrollment: 30
Sponsor: Nakhia Impex LLC
Location: Qingdao Hynaut Laboratory Qingdao Shandong
Summary
This is a prospective, single-arm, open-label, pilot clinical study to evaluate the efficacy and safety of overnight occlusive topical application of 10% high-concentration 35 kDa hyaluronan (HA35) gel for facial aesthetic improvement. Eligible participants will receive overnight occlusive application once every 2 days for a total of 5 treatments over 10 days. The primary objectives are to assess changes in facial subcutaneous fat appearance, inflammatory erythema, skin radiance, and nasal alar pore enlargement after 1 and 5 applications. Safety and local tolerability will be evaluated throughout the study period. This is a minimal-risk, non-pharmacological, non-invasive aesthetic intervention.
Eligibility Criteria
Inclusion Criteria:
* Age 18-60 years, male or female
* Seeking non-invasive improvement of facial appearance
* Presenting with at least one of: facial subcutaneous fat accumulation, facial erythema, skin dullness, nasal alar pore enlargement
* Baseline NRS score ≥2 for at least one target parameter
* Ability to complete self-assessments
* Signed written informed consent
Exclusion Criteria:
* Facial aesthetic treatments (injection, laser, fat reduction, peeling) within 2 weeks
* Active facial dermatitis, infection, or open wounds
* Known hypersensitivity to hyaluronan or gel components
* Pregnant or lactating women
* Severe systemic disease or uncontrolled medical condition
Source: ClinicalTrials.gov (NCT07584811). StuddyBuddy aggregates publicly available trial information.